Works matching IS 22250719 AND DT 2025 AND VI 13 AND IP 2

Results: 8

Ferrochelatase Gene Variants Associated with Cholestasis in Adults: A Case Report.

Published in:

Journal of Clinical & Translational Hepatology, 2025, v. 13, n. 2, p. 173, doi. 10.14218/JCTH.2024.00304

By:

Xiaona Lu;
Kun Liu;
Wenlan Zheng;
Xuemei Zhang;
Jia Shi;
Shihan Yu;
Yueqiu Gao;
Hai Feng;
Zhuo Yu

Publication type:

Article

Significant Response to Palbociclib Plus Lenvatinib as Second-line Treatment for CDKN2A/2B Deletion Intrahepatic Cholangiocarcinoma: A Case Report.

Published in:

Journal of Clinical & Translational Hepatology, 2025, v. 13, n. 2, p. 169, doi. 10.14218/JCTH.2024.00404

By:

Kai Liu;
Ziyue Huang;
Lijin Zhao;
Haitao Zhao

Publication type:

Article

Ursodeoxycholic Acid for the Management of Drug-induced Liver Injury: Role of Hepatoprotective and Anti-cholestatic Mechanisms.

Published in:

Journal of Clinical & Translational Hepatology, 2025, v. 13, n. 2, p. 162, doi. 10.14218/JCTH.2024.00325

By:

Bessone, Fernando;
Hillotte, Geraldine L.;
Tamagnone, Norberto;
Arnedillo, Daiana;
Roma, Marcelo G.

Publication type:

Article

Exosome-mediated Crosstalk in the Tumor Immune Microenvironment: Critical Drivers of Hepatocellular Carcinoma Progression.

Published in:

Journal of Clinical & Translational Hepatology, 2025, v. 13, n. 2, p. 143, doi. 10.14218/JCTH.2024.00302

By:

Yifei Ge;
Lixue Jiang;
Qingfu Dong;
Yi Xu;
Wai Ping Yam, Judy;
Xiangyu Zhong

Publication type:

Article

Peripheral Blood CD4<sup>+</sup>/CD8<sup>+</sup> T Cell Ratio Predicts HBsAg Clearance in Inactive HBsAg Carriers Treated with Peginterferon Alpha.

Published in:

Journal of Clinical & Translational Hepatology, 2025, v. 13, n. 2, p. 130, doi. 10.14218/JCTH.2024.00240

By:

Fengping Wu;
Chenrui Liu;
Ling He;
Yikai Wang;
Xin Zhang;
Miaoxian Li;
Rui Lu;
Pei Kang;
Mei Li;
Yaping Li;
Xiaoli Jia;
Shuangsuo Dang

Publication type:

Article

Plasma Extracellular Vesicle-derived MicroRNA Associated with Human Alpha-1 Antitrypsin Deficiency-mediated Liver Disease.

Published in:

Journal of Clinical & Translational Hepatology, 2025, v. 13, n. 2, p. 118, doi. 10.14218/JCTH.2024.00253

By:

Oshins, Regina;
Zhiguang Huo;
Greenberg, Zachary;
Clark, Virginia;
Duarte, Sergio;
Huiping Zhou;
West, Jesse;
Mei He;
Brantly, Mark;
Khodayari, Nazli

Publication type:

Article

Sodium Butyrate Inhibits Necroptosis by Regulating MLKL via E2F1 in Intestinal Epithelial Cells of Liver Cirrhosis.

Published in:

Journal of Clinical & Translational Hepatology, 2025, v. 13, n. 2, p. 105, doi. 10.14218/JCTH.2024.00221

By:

Yimeng Zhou;
Yang Ding;
Yanwei Li;
Qiuju Sheng;
Chao Han;
Yaoxin Fan;
Ziyi Wang;
Bingchao Lu;
Xiaoguang Dou;
Chong Zhang

Publication type:

Article

Risk of Coronary Artery Disease in Patients with Liver Cirrhosis: A Systematic Review and Meta-analysis.

Published in:

Journal of Clinical & Translational Hepatology, 2025, v. 13, n. 2, p. 93, doi. 10.14218/JCTH.2024.00226

By:

Chunru Gu;
Liyan Dong;
Lu Chai;
Zhenhua Tong;
Fangbo Gao;
Ageno, Walter;
Gomes Romeiro, Fernando;
Xingshun Qi

Publication type:

Article